NAUT

Nautilus Biotechnology Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 5/10
  • Value↑ 5/10
Nautilus Biotechnology sales and earnings growth
NAUT Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 14.81%
  • FCF Y/Y↑ 12.11%
Nautilus Biotechnology gross and profit margin trends
NAUT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -25.71%
Nautilus Biotechnology net debt vs free cash flow
NAUT Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.3
  • Interest coverage↓ NA

Nautilus Biotechnology stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks